A CE-mark is not enough to bring medical device products to the market. Claudia Wild, EUnetHTA member, talks on synergies between medical device regulation (MDR) clinical evidence demand and synergies with HTA processes at the MedTech Access Leaders Forum in Berlin Dec 3-5, 2018. Read more about the event here: https://lnkd.in/gGnXfp5
New publication: Finasteride treatment and male breast cancer: a register-based cohort study in four Nordic countries.
By pooling Nordic health data on medical devices & pharmaceuticals, and analyzing it on the micro-level, we tap into the full potential of big data. The Nordic health registers cover 26 mill. people from birth to death. Read about our most recent safety study, pooling data from 4 Nordic countries, here: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5773955/
ApHER participated at ISPOR Europe 2018 and presented a study “COSTS OF MULTIPLE SCLEROSIS IN DENMARK: A REGISTER BASED STUDY”. The unique registers in Denmark allow us to include in the study all individuals with Multiple Sclerosis (MS) in Denmark. All Individuals with MS in 2014 were ascertained and characterized by treatment from the Danish health [...]
ApHER participated at the cancer research days presenting the CEDAR study, a nationwide, observational study including all patients living with cancer of the lung, breast, bladder, ovary, and prostate as of 31st December 2005 and all patients first-time diagnosed from then up to 31st December 2015. Patients are followed from date of first diagnosis until death [...]
Monday the 28th of August ApHER participated in the DHL Relay in Copenhagen. Despite of huge amounts of rain, all 5 ApHER runners completed their 5km run in a total time of 2h 34m. The DHL Relay is the world's biggest running event with more than 200.000 participants in 2017.
It’s our party. But it ends today. By Aug 1st the global natural resources available for 2018 are spent. Anything beyond this is excess consumption. ApHER marks Earth Overshoot Day by venturing into projects improving the environment that surrounds us. Protecting our health. What can you do to #movethedate? Cancel your flight and use Skype. Use your [...]
Six out of ten of the sclerosis patients who are not in disease-modifying treatment do not attend annual follow-ups. This means that the patients do not receive the symptom management or rehabilitation they need. These results come from a new study by ApHER conducted in collaboration with the Danish Multiple Sclerosis Society, presented by Prof. Anders Green [...]
A poorly regulated diabetes patient is costly for both the public healthcare system and the private insurance companies. In a recent cost-effectiveness study of the LIVA platform ApHER concludes that there is a desirable investment return by managing diabetes patients digitally through online lifestyle coaching. Read the article at LIVA Healthcare here.